Transient induction of the cyclin E gene in late G 1 gates progression into S. We show that this event is controlled via a cyclin E repressor module (CERM), a novel bipartite repressor element located near the cyclin E transcription start site. CERM consists of a variant E2F-binding site and a contiguous upstream AT-rich sequence which cooperate during G 0 /G 1 to delay cyclin E expression until late G 1 . CERM binds the protein complex CERC, which disappears upon progression through G 0 -G 1 and reappears upon entry into the following G 1 . CERC disappearance correlates kinetically with the liberation of the CERM module in vivo and cyclin E transcriptional induction. CERC contains E2F4/DP1 and a pocket protein, and sediments faster than classical E2F complexes in a glycerol gradient, suggesting the presence of additional components in a novel high molecular weight complex. Affinity purified CERC binds to CERM but not to canonical E2F sites, thus displaying behavior different from known E2F complexes. In cells nullizygous for members of the Rb family, CERC is still detectable and CERMdependent repression is functional. Thus p130, p107 and pRb function interchangeably in CERC. Notably, the CERC-CERM complex dissociates prematurely in pRb -/-cells in correspondence with the premature expression of cyclin E. Thus, we identify a new regulatory module that controls repression of G 1 -specific genes in G 0 /G 1 .
Introduction
The cyclin E/cdk2 kinase is an essential, rate-limiting regulator of the G 1 to S phase transition of the mammalian cell cycle (Keyomarsi and Herliczek, 1997) . It provides a threshold for entry into the S phase, probably acting as a master switch for an unknown event essential for the initiation of DNA replication (Krude et Duronio et al., 1998) . Cyclin E expression is tightly regulated during cell cycle progression. Quiescent cells do not express cyclin E, and upon their entry into the cell cycle, the levels of cyclin E mRNA and protein rise sharply during a narrow window of time that precedes entry into S phase (Keyomarsi and Herliczek, 1997) . Several lines of evidence suggest that this induction is controlled by the transcription factor E2F. E2F's transcriptional activity is the result of the heterodimeric association of two families of proteins, E2Fs (E2F1-6) and DPs (DP1-2) (for reviews on E2F, see Sardet et al., 1997; Dyson, 1998; Nevins, 1998) . They bind to DNA as free heterodimers E2F/DP or associated in larger complexes containing members of the pRB tumor suppressor family (the 'pocket proteins': pRB, p107, p130) and of the cyclin/cdk family (cyclin E/cdk2 and cyclin A/cdk2 associates physically with p107 and p130). Three successive and overlapping 'waves' of E2F complexes can be detected throughout the cell cycle, i.e. E2F/DP-pocket protein trimeric complexes that are predominant in G 0 -arrested and early G 1 cells, 'free E2Fs' (E2F/DP heterodimers) with an abundance that reaches a maximum at the G 1 /S phase boundary, and five component E2F complexes (E2F/DP-pocket proteins-cyclin/cdk2) which are predominant during the rest of the cell cycle and in exponentially growing cells. When bound on promoters, these E2F-complexes can act as activators ('free' E2F1-5/DP heterodimers) or as repressors (pocket protein-associated complexes). Depending on promoter context, the association of E2Fs with pocket proteins has been described to inhibit E2F/DP-mediated transactivation or, more recently, to actively repress transcription via pocket protein interactions with histone deacetylases and/or with general transcription factors.
Several lines of evidence suggest that E2F-mediated activation and repression would be involved in the control of the cyclin E promoter. Thus, (i) in Drosophila, genetic studies indicate that cyclin E is the limiting downstream target of an E2F-mediated transactivating event (Duronio et al., 1995 (Duronio et al., , 1998 . (ii) In mammalian cells in culture, the disruption of E2F-pocket protein repressor complexes by viral oncoproteins adenovirus E1A (AdE1A) or herpesvirus 16 E7 (HPV16 E7) leads to a rapid induction of the endogenous cyclin E gene (Spitkovski et al., 1994; Zerfass et al., 1995) . The same rapid induction is also observed following E2F1 overexpression Othani et al., 1995; Botz et al., 1996; Geng et al., 1996) . (iii) The cyclin E gene is de-repressed and induced earlier than normal relative to S phase entry in RB -/-mouse embryo fibroblasts (MEFs) (Herrera et al., 1996; Hurford et al., 1997) and in p107 -/-MEFs from a genetic background enriched for BALB/cJ (LeCouter et al., 1998) . (iv) The GC-rich region of the transcription initiation site of the cyclin E gene is highly conserved between the mouse ( Figure 2C ) (Botz et al., 1996) and human promoters (Othani et al., 1995; Geng et al., 1996) and contains several putative binding sites for SP1 and E2F. The combined mutation of two of these E2F sites in the human cyclin E promoter leads to partial de-repression of the promoter in G 1 (Othani et al., 1995) , whereas the mutation of a nearby third variant E2F site prevents the G 1 /S induction of the mouse cyclin E promoter (Botz et al., 1996) .
These results are consistent with increasing evidence that some E2F-binding sites might exert a positive effect on transcription whereas others would be involved only in repression. Consistent with this, it was found that mutation of E2F binding sites within the adenovirus E2, the mammalian DHFR and cyclin E promoters block the G 1 /S induction of those genes, whereas inactivation of E2F sites within the B-myb, E2F1, E2F2, orc1, p107, RB1 and cdc2 genes leads to a clear upregulation of these genes in G 0 and/or G 1 phase of the cell cycle (for review see Sardet et al., 1997; Dyson, 1998; Nevins, 1998) .
The molecular mechanism that determines whether these E2F sites will function as a positive or negative regulatory element is still poorly understood. In the case of the E2F-repressor sites of the B-myb (Lam and Watson, 1993) and cdc2 promoters (Tommasi and Pfeifer, 1995) , analyses of DNA-protein contacts by in vivo footprinting have shown that these sites were occupied by proteins only during G 1 when these promoters are inactive (Tommasi and Pfeifer, 1995; Zwicker et al., 1996, Zwicker and . Notably, they remained unoccupied after the release of repression despite the presence of transcriptionally active E2F factors in the nucleus at that time. This observation suggested that the periodic occupation of these elements by an E2F-repressor complex was likely to represent the molecular basis for the cell cycle-specific transcriptional repression of these genes . This also suggested that these E2F-repressor elements might display subtle characteristics which differentiate them from E2F-activator sites. Consistent with this idea, the same authors have shown that the E2F-mediated repression of the B-myb promoter is dependent on a contiguous co-repressor element which resembles the cell cycle homology region (CHR) (Bennett et al., 1996; Liu et al., 1996) , a sequence previously established as being important for the cell cycle-dependent expression of the cyclin A and cdc25C genes Zwicker et al., 1995) . In the promoter of these genes, the CHR (5Ј-A/TG/TGAA-3Ј) is cooperating with a contiguous GCrich motif (5Ј-G/CGCGG-3Ј), termed CDE (cell cycledependent element) Zwicker et al., 1995) or cell cycle regulatory element (CCRE) (Huet et al., 1996) , to form a bipartite cell cycle-regulated repressor element . Other similarities exist between CDE-CHR and E2F-CHR twocomponent repressor modules: (i) inactivation of either region of the bipartite repressor module results in high constitutive transcriptional activity of these promoters throughout the cell cycle ; (ii) these elements are also making specific contacts with as yet unidentified proteins during G 1 , when these promoters are inactive and these contacts are lost when the genes are expressed, i.e. at the G 1 /S transition for cyclin A and cdc2 and in late S for cdc25C Tommasi and Pfeifer, 1995; Zwicker et al., 1995 Zwicker et al., , 1996 Huet et al., 1996) ; (iii) finally, the CDE-CHR and E2F-CHR two-component repressor modules are both located immediately upstream of the initiation site, raising the possibility that their occupancy somehow interferes with the process of transcriptional initiation . Altogether, there is increasing evidence that both E2F-and CDE-mediated repression might depend on promoter-specific co-repressor elements such as CHR. However, how this co-repressor functions is still unknown.
To understand what determines the negative effect of E2F sites, we performed detailed in vivo and in vitro analyses of the transcription start site region of the mouse cyclin E promoter. We provide compelling evidence that one of the E2F sites located in this promoter region is part of a novel type of two-component repressor module, termed CERM (cyclin E repressor module). This bipartite repressor element acts as a cell cycle clock, necessary for the precise timing of cyclin E induction at the G 1 /S transition. CERM selectively binds a novel E2F complex, termed CERC (for cyclin E repressor complex), the size and binding behavior of which differ from known E2F complexes. CERM/CERC dissociation correlates kinetically with cyclin E transcriptional induction. This finding bring new insights into the mechanism by which E2F controls the cell cycle-dependent repression of G 1 -specific genes in G 0 /G 1 .
Results
In vivo occupation of a variant E2F-binding site (E2FX) and of a contiguous AT-rich sequence coincides precisely with repression of cyclin E gene transcription We first analyzed the cell cycle-dependent regulation of the endogenous mouse cyclin E promoter. Swiss 3T3 fibroblasts made quiescent by serum deprivation were stimulated to reenter the cell cycle by serum addition. Ninety-five percent of the cells synchronously proceed through a complete cell cycle over a 24 h period. The G 1 phase of the cycle takes 12 h following release from G 0 ( Figures 1A and 3) . Four hours later, the cells have all entered S phase, followed by G 2 /M 20 h post stimulation ( Figure 1A) . By 24 h, the cells have passed through mitosis and re-entered G 1 ( Figure 1A) . Cyclin E mRNAs are almost undetectable in G 0 and early/mid G 1 , then peak transiently at the G 1 /S phase boundary and finally return to a basal level as the cells progress through G 2 , M and into the G 1 phase of the next cycle ( Figure 1B) .
To check whether the previously identified E2F sites located in the transcription start site region of the cyclin E promoter were truly involved in this brief spurt of expression we performed a detailed in vivo analysis of the DNA-protein contacts on these sites during the cell cycle, using a dimethyl sulfate/ligation-mediated PCR (DMS/LMPCR)-based in vivo genomic footprinting technique ( Figure 2A and B, and summary in C). Swiss 3T3 cells, were incubated with DMS at various time points following serum readdition. In vivo DMS-methylated DNA was then extracted and used to generate cyclin E promoter specific ladders by LMPCR (Mueller and Wold, 1989; Le Cam et al., 1999) . We designed our LMPCR primers ( Figure 2C ) to cover the 150 bp surrounding the major transcription start site (Botz et al., 1996) .
Representative genomic footprints of this region obtained with G 0 and S phase (16 h after serum stimulation) cells are shown in Figure 2A and B. In the immediate vicinity of the major initiation site, we observed two regions of DNA-protein contacts. One is a GC-rich sequence [nucleotides (nts) -30/-1] located immediately upstream of the major transcription start site, in which the G residues remain protected throughout the cell cycle ( Figure 2A ; termed E2FI/SP1). This constitutively protected region encompasses several overlapping SP1 binding sites and the variant E2F binding site (nts -18/-12) described previously (Botz et al., 1996) , termed the E2FI site. The E2FI site was shown to be important for the cell cycle activation of the mouse cyclin E promoter, since its mutation significantly decreased G 1 /S-specific activation of the cyclin E promoter in synchronized NIH 3T3 cells (Botz et al., 1996) . The constitutive occupation of this site resembles that of other E2F DNA binding sites acting as positive regulatory elements in the DHFR (Wells et al., 1996) and TK (Karlseder et al., 1996) promoters.
The second region of DNA-protein contacts is located immediately downstream from the major transcription start site and is centered around another variant E2F site that we termed E2FX (nts ϩ28 /ϩ5, TGTCCCGC). Notably, the protection of G residues within this site and the hypermethylation of a nearby guanine residue vary during the cell cycle (Figure 2A and B) . DNA-protein contacts on both DNA strands are clearly visible when the cyclin E promoter is silent, i.e. in serum-starved cells and during most of the G 1 phase (Figure 2A ; unpublished data). In contrast, the presence of proteins on that site is barely detectable 12 and 16 h following serum addition, times which coincide precisely with the onset of cyclin E transcription in late G 1 and S (Figure 1 ). In addition, longer exposures of the same autoradiographs reveal a protection/occupation on a stretch of A residues (minus strand of DNA) located immediately upstream of the E2FX site (nts ϩ20/ϩ28) ( Figure 2B ). The protection of this AT-rich sequence in the minor groove of DNA parallels that of the E2FX site; it is strong in serum-starved cells and almost undetectable at 16 h following serum addition. Moreover, we also repeatedly observed that the E2FX site and the AT-rich sequence are both partially protected again 24 h post-stimulation (unpublished data), a time that coincides with the re-entry of cells into G 1 and with the complete downregulation of cyclin E transcription ( Figure 1) .
The DNA-protein contacts observed on this AT-E2FX region resemble those described on bipartite CDE/CCRE/ E2F-CHR repressor modules in the cyclin A, cdc25 and B-myb promoters Tommasi and Pfeifer, 1995; Zwicker et al., 1995 Zwicker et al., , 1996 Huet et al., 1996) .
Indeed, like the E2FX site, the CDE/CCRE/E2F element contacts proteins in the DNA major groove (G residues contacted) (Tommasi and Pfeifer, 1995; Zwicker et al., 1995 Zwicker et al., , 1996 Huet et al., 1996) , whereas the AT sequence and the CHR are both contacted by proteins on adenines in the minor groove Liu et al., 1996) . Moreover, in vivo occupancy of CDE/E2F and AT-E2FX sequences are both lost with kinetics, which correlates very well with the transcriptional induction of the genes (Tommasi and Pfeifer, 1995; Zwicker et al., 1995 Zwicker et al., , 1996 Huet et al., 1996) .
Thus, although the position (3Ј side of the E2FX site) and the sequence of the AT-rich sequence differ from that of previously described CHR elements, these results provide the first hint that the cyclin E promoter might be regulated by a two-component repressor module that we named CERM.
CERM is a bipartite cell cycle-regulated repressor element acting to delay cyclin E expression in late G 1 To test the role of the E2FI-site region and of the CERM, we mutated these two elements in the mouse cyclin E promoter. All mutant constructs, as well as the wild-type (wt) promoter, were stably transfected into Swiss 3T3 cells and their expression analyzed during the cell cycle ( Figure 3 ). Reporter cells populations were assayed by Northern blot analysis (unpublished data) and measurements of luciferase activity (Figure 3) .
The wt cyclin E promoter-luciferase construct (proCE) yields a 12-to 15-fold increase with kinetics that reflect the activation of the endogenous cyclin E gene (compare Figure 1B with 3) . In contrast, the proCE-ΔE2FI/SP1 construct shows extremely low activity and is not induced in late G 1 (Figure 3 ). This mutation targets all the guanosines protected in vivo within the E2FI region. We conclude that this constitutively occupied E2FI region is The in vitro lane refers to similar LMPCR carried out with DMS-methylated naked DNA. Amplified DNA ladders that are visible correspond to guanosines of both strands of the mouse cyclin E promoter around the start site (black arrows). Protected and hyperreactive residues detected between in vitro-and in vivo-methylated DNAs are indicated as circles and stars, respectively. Putative binding sites for E2F and SP1 are indicated. (B) Although DMS reacts predominantly with G residues, it also methylates adenine (N-3-methyladenine) with a lower efficiency. Autoradiographs are overexposed to show the less efficient cleavage of a stretch of methylated adenine (minus strand) contiguous with the E2FX site. The protection/ occupation of these bases paralleled that of the E2FX site; strong in serum-starved cells (G 0 ) and almost undetectable at 16 h following serum addition (S phase). (C) Summary of in vivo protections identified around the major transcription start site of the mouse cyclin E promoter. In vivo footprints shown above ( Figure 2A and B) identify two types of DNA-protein contacts: (i) several GC-rich regions remained protected on both strand, by proteins throughout the cell cycle (labeled 'c.o.' for constitutive occupation); (ii) a region of DNA-protein contacts centered around a variant E2F site, termed E2FX, and a contiguous AT-rich sequence (nts ϩ20/ϩ35), together termed CERM, with a protection that varies during the cell cycle. ASCE and SCE oligonucleotides used for LMPCR are indicated. Fig. 3 . The two-component regulatory element (AT-E2FX), termed CERM, acts to delay cyclin E expression in late G 1 . Swiss 3T3 fibroblasts were stably transfected with luciferase reporter constructs driven by the mouse cyclin E promoter (proCE) or by the corresponding CERM mutants bearing mutations within either the AT-rich sequence (proCE-ΔCERM/E2FXmut) or within the E2FX site (proCE-ΔCERM/E2FXmut). Cells were also transfected with proCE-ΔE2FI/SP1, a reporter construct driven by the cyclin E promoter bearing mutations within the promoter region referred to as E2FI/SP1 in Figure 2C . Neomycin-selected populations of Swiss 3T3 transfectants stably expressing these reporters were serum starved and restimulated by serum as described in Figure 1 . The resulting colonies were pooled and used for luciferase assays. Luciferase activities (left axis) were plotted as the degree of stimulation relative to luciferase activity measured in quiescent cells. The results represent the average of three experiments using two independent populations of transfectants for each reporter. Histograms indicate the percentage of cells in S phase monitored in the same experiments by measurement of BrdU incorporation in DNA (right axis).
essential for the transcriptional activity of the cyclin E promoter. We did not pursue further the molecular analysis of this regulatory region since others have done so (Botz et al., 1996 ; B.Vogt and P.Jansen-Dürr, in preparation), but rather focused our efforts on the cell cycle-regulated element CERM.
To test the two-component repressor hypothesis, we introduced mutations separately into the two protected sequences of CERM, either the E2FX site (TGTCCCGC→TGTA-GAGC) (proCE-ΔCERM/E2Fmut) or the AT-sequence (TTTTAAAT→TCTGCAAT) (proCE-ΔCERM/ATmut). Figure 3 shows that the cell cycle kinetics of either of these promoter constructs are accelerated, i.e. they are prematurely activated in mid-G 1 compared with the wt cyclin E promoter. More precisely, they are still silent in quiescent cells and at early time-points following serum stimulation; however, they give rise to 12-to 15-fold increased luciferase activity 4 h earlier than the wt promoter. This functional analysis suggests that the AT-rich and the E2FX sequences both act to delay cyclin E expression in late G 1 . This also suggests that together they form the bipartite cell cycle regulatory module CERM that functions solely as a transcriptional repressor element in G 0 and G 1 without affecting the level of induction at the G 1 /S transition.
Identification of a cellular activity (CERC) that binds CERM in strict correlation with the silencing of cyclin E transcription
To identify the proteins that bind this novel cell cycleregulated repressor module, we used electrophoretic mobility shift assays (EMSAs) with a DNA probe spanning this region of the mouse cyclin E promoter (probe CERM). Whole-cell extracts from quiescent Swiss 3T3 cells generated a major DNA-protein complex with this probe, termed CERC ( Figure 4A ). The same complex was also observed using nuclear extracts (unpublished data). This complex requires both the E2FX and the AT-rich sequences, since it is not seen in EMSAs carried out with a DNA probe bearing mutations either in the E2FX site or the contiguous AT-rich sequence ( Figure 4A ). This is confirmed by competition using a 100-fold molar excess of wt or mutant unlabeled CERM oligonucleotides (see Figure 7B , upper right panel).
This result suggests that a cellular activity (CERC) requires both the AT-rich sequence and the E2FX site to form the complex, which is in agreement with the functional analysis of CERM (Figure 3) showing that mutating either the AT-rich or the E2FX sequences accelerates cyclin E promoter activation.
Since the in vivo occupation of CERM varied during the cell cycle, it seemed likely that CERC activity would also be cell cycle regulated. We prepared Swiss 3T3 cellular extracts at 4 h intervals during cell cycle progression and tested them by EMSAs ( Figure 4B ). CERC is detectable in G 0 and early/mid-G 1 phase extracts, but then disappears between late G 1 and M phase, finally reappearing as the cells progress into the next G 1 phase.
Thus, the kinetics of protein-DNA complex formation observed on CERM in vitro correlates perfectly with the kinetics of its in vivo protection and of cyclin E promoter silencing, thereby implicating CERC as the cell cycleregulated repressor that mediates the CERM-dependent control of cyclin E gene transcription.
The repressor complex CERC contains specific members of the E2F, DP and pocket protein families We then set out to characterize the proteins present in CERC. Although the sequence of the E2FX site (TGTCCCGC) differs from a consensus E2F-binding site sequence (TTTCGCGC), we nevertheless tested whether CERC contained E2Fs and E2F-associated proteins using antibodies directed against pocket proteins, E2Fs and DP proteins in EMSAs ( Figure 5 ). CERC is completely supershifted by an anti-p130 antibody in G 0 and through G 1 until it disappears in S, G 2 and M phases. Interestingly, p107 almost completely replaces p130 in CERC when cells move into the next G 1 phase, 24 h after serum stimulation ( Figure 5A ). p107 and p130 have been shown to bind a specific subset of E2F family members, namely E2F4 and E2F5, in association with DP1 (Sardet et al., 1995 (Sardet et al., , 1997 Moberg et al., 1996; Dyson, 1998; Nevins, 1998) . Consistent with this observation, both types of CERC are almost completely disrupted by a polyclonal antibody directed against E2F4 and supershifted by an anti-DP1 ( Figure 5B and C) . Notably, CERC from Swiss 3T3 cells fails to react with antibodies directed against pRB ( Figure 5A ) or other E2F species (the presence of E2F1, E2F3 and E2F5 was also tested; unpublished data) at any phase of the cell cycle.
The pattern of EMSA complexes formed on the CERM probe is surprising, since it does not reflect the cell cycle distribution of E2F complexes usually seen with probes harboring a consensus binding site for E2F (Sardet et al., 1997; Dyson, 1998; Nevins, 1998) . To address this discrepancy, we also analyzed the complexes formed by our Swiss 3T3 extracts on a double-stranded oligonucleotide EMSAs showing E2F complexes formed with the E2F site of the adenovirus E2 promoter during the cell cycle. Cellular extracts prepared from synchronized Swiss 3T3 cells as described in Figure 4 were analyzed by EMSA with a double-strand oligonucleotide containing the consensus binding site for E2F from the adenovirus E2 promoter (probe: E2). Three successive 'waves' of E2F complexes (a, b and c) are observed according to their reactivity with specific antisera and their sensitivity to DOC (data not shown): (c) E2F/DP heterodimers ('free E2Fs'); (b) E2F/DP-pocket protein heterotrimers; and (a) E2F/DP-pocket protein-cyclin A/E complexes.
bearing the E2F-binding site of the adenovirus E2A promoter ( Figure 6 ). Specificity controls, and deoxycholate (DOC) sensitivity and antibody reactivity tests were also carried out (unpublished data). The cell cycle distribution of E2F complexes in Swiss 3T3 G 0 appears to be similar to that described previously (e.g. Moberg et al., 1996; Smith et al., 1996) .
Thus, although multiple E2F complexes can be detected throughout the cell cycle with a consensus E2F probe, the regulatory element CERM binds only a defined subset of those. Notably, it does not associate with 'free' E2Fs that are abundant in our extracts at the G 1 /S transition. This observation, and the fact that CERC always contains a member of the pocket protein family, are consistent with our mutational analyses showing that CERM exclusively mediates transcriptional repression. We conclude that the cell cycle distribution and composition of CERC is in perfect agreement with the expected behavior of the repressor bound on CERM.
CERC is a novel high molecular weight E2F complex that differs from previously described E2F complexes What might explain the surprising binding behavior of CERM compared with 'regular' E2F sites? First, CERM might be a low affinity binding site for free E2Fs and a high affinity one for E2F-pocket protein complexes. Figure  7 shows that this is unlikely to be the case, since neither recombinant free E2Fs (E2F1/DP1, E2F4/DP1) (Sardet et al., 1995) nor p130-E2F4/DP1 trimeric complex (Vairo et al., 1995) are able to bind efficiently to CERM ( Figure  7A , right panel), while they all bind to the E2 probe with comparably high efficiency ( Figure 7A, left panel) . Moreover, the E2 probe which strongly binds p130-E2F4/ DP1 complexes is unable to compete for CERC binding on CERM. Indeed, Figure 7B shows that the CERM and the E2 probes poorly compete for binding to the other in gel-shift assays performed with cellular extracts prepared from G 0 -arrested Swiss 3T3 cells.
Alternatively, the cellular CERM-binding activity might also require a protein(s) in addition to E2F4/DP1 and p130 for efficient binding. Consistent with this, upon overexposure of autoradiographs, we observed a weak complex formed between recombinant p130-E2F4/DP1 proteins 5) ; E2F1/DP1 (lanes 2 and 6); E2F4/DP1 (lanes 3 and 7); p130-E2F4/DP1 (lanes 4 and 8). (B) CERM and E2 probes compete poorly for binding of cellular proteins to each other. Similar amounts of whole-cell extracts (5 μg) prepared from G 0 -arrested Swiss 3T3 cells were analyzed by EMSA with a CERM probe (upper panels) or with an E2 probe (lower panels) in presence of 0-, 12-, 25-, 50-and 100-fold molar excess of unlabeled E2 or CERM competitor as indicated above the lanes. As a control, competitions were also performed with a 100-fold molar excess of E2 and CERM oligonucleotides bearing mutations within their E2F site (E2mut and CERMmut as indicated above the lanes). Cellular E2F complexes labeled as b and c are defined in Figure 6. and the CERM probe which clearly migrated faster than cellular CERC (unpublished data).
This additional component might be part of a novel E2F complex or might bind to CERM independently. To address this point, we first tested whether the protein complex that binds CERM was larger than that of 'classical' E2F complexes. We fractionated nuclear or wholecell extracts from G 0 -arrested Swiss 3T3 cells in native glycerol gradients and tested the fractions by EMSA for both CERM (CERM probe) and whole E2F (E2 probe)-binding activities ( Figure 8B and A, respectively) . The bulk of E2F activity (containing mainly p130-E2F4/DP1; unpublished data; Vairo et al., 1995; Moberg et al., 1996 ; (E) Fractionated E2F and CERC complexes formed on the E2 and CERM probes are specific for these probes. EMSA complexes formed between the E2 probe and fraction 9 (lane 1) are competed out by a 100-fold molar excess of wt unlabeled E2 probe (lane 2), but not by the corresponding mutated competitor (E2 mut) (lane 3). Similarly, CERC complex formed between CERM and fraction 11 (lane 4) is competed out by a 100-fold molar excess of wild-type CERM probe (lane 5) but not by the corresponding E2FX site-mutated competitor (CERM/E2FXmut) (lane 6). Smith et al., 1996) was detected in fractions 7-13, with a maximum in fraction 9, whereas CERC appeared in fraction 10 and persisted until fraction 16, with a maximum in fraction 11 ( Figure 8B ). p130 was detected by Western blot analysis in fractions 7-15, a distribution that fits both the E2F-and CERM-binding activities ( Figure 8C) .
Thus, the sedimentation profile of CERC in G 0 is clearly different from that of p130-E2F4/DP1 complexes that are capable of binding a 'classical' E2F site, strongly suggesting that CERC represents a distinct protein complex containing an additional protein(s). Moreover, this clear difference in size is not restricted to G 0 complexes since we also observed it in extracts of Swiss 3T3 that have quantitatively entered the G 1 phase cells (stimulated to grow for 8 h) (unpublished data).
To test further whether CERC activity corresponds to . Affinity purified CERC complex is able to bind the CERM two-component regulatory element but not the consensus E2F site of the adenovirus E2 promoter. CERC was affinity purified from 1 mg of G 0 -arrested Swiss 3T3 cellular extracts using biotinylated doublestranded CERM oligonucleotides bound on streptavidin magnetic beads as described in Materials and methods. One-tenth of the CERC released from the beads was analyzed by EMSA with either the CERM probe (lane 2-4) or the E2 probe (lane 6). To show that input extracts contained CERC and known E2F-complexes, 6 μg of G 0 -arrested Swiss 3T3 cellular extracts were also analyzed with the CERM (lane 1) or the E2 probe (lane 5). The binding of affinity purified CERC complex on CERM probe (lane 2) is competed out by a 100-fold molar excess of wt CERM probe (lane 3) but not by the corresponding E2FX site-mutated competitor (CERM/E2FXmut) (lane 4).
a novel entity that differs from known E2F complexes, we affinity purified CERC from G 0 -arrested Swiss 3T3 cellular extracts using a biotinylated CERM oligonucleotide bound on streptavidin magnetic beads. After elution from the beads, we tested the capacity of the purified complex to reassociate with a CERM and an E2 probe. The protein complexes purified reassociate with the cyclin E but not the E2 probe ( Figure 9 ). We conclude that: (i) this result confirms that CERM is a low affinity binding site for 'regular' E2F complexes since they are not affinity purified by the CERM beads; (ii) CERC displays a unique specificity for CERM, i.e. a binding behavior that differs from that of known E2F complexes; and (iii) it strongly suggests that the additional proteins present in CERC are stably associated with E2F-pocket proteins and modify their DNA binding behavior, otherwise the E2F component of CERC should be able to bind the E2 probe after its release from the beads. Altogether, these experiments show that CERC is a high molecular weight complex, stable in solution, which contains E2F4/DP1, a pocket protein and at least one additional unidentified protein. We demonstrate unambiguously that this repressor complex represents a novel E2F complex that differs in size and binding behavior from E2F complexes described previously.
The pocket proteins pRB, p107 and p130 are interchangeable in CERC Our results suggest that, in Swiss 3T3 cells, CERC is essential for the correct timing of cyclin E expression and contains p107 or p130 but not pRB. This conclusion is seemingly at odds with other reports showing that cyclin E expression is altered in RB1 -/-MEFs (premature expression in G 1 ) but not in p107 -/-p130 -/-double knockout MEFs (Herrera et al., 1996; Hurford et al., 1997; . This apparent discrepancy prompted us to examine the behavior of the CERM regulatory element in these knockout cells (Figure 10) .
First, we performed in vivo genomic footprinting and gel-shift analyses of the CERM module in serum-starved wt, RB1 -/-, p130 -/-and p107 -/-p130 -/-primary MEFs (Cobrinik et al., 1996; Hurford et al., 1997) . In each cell type, we detected in vivo protection of CERM ( Figure 10A ) and a CERC-like activity ( Figure 10B ). However, antibody interference assays demonstrates that the pocket protein composition of these CERCs differs. We detect predominantly p130 in wt and RB -/-MEFs, p107 in p130 -/-cells and pRB in p107 -/-p130 -/-double knockout cells ( Figure 10B ). In each case, E2F4 is present in CERC. We also detect small amounts of pRB in p107 -/-and p107 in RB1 -/-CERC complexes. These observations are consistent with reports showing that the relative amount of the various pocket proteins varies in these knockout cells (Hurford et al., 1997; .
The fact that a CERC-like activity containing pRB exists in p107 -/-p130 -/-suggests that pRB is able to compensate for the p107/p130 function in CERC-mediated repression in these cells. This provides an explanation of the normal regulation of cyclin E expression in these double knockout cells (Hurford et al., 1997; . On the other hand, the presence of CERC on CERM in quiescent RB -/-cells is unconsistent with the mistiming of cyclin E expression during G 1 in this genetic background (Herrera et al., 1996; Hurford et al., 1997; .
To address this, we decided to explore further the behavior of CERM/CERC during the G 0 /G 1 -S progression in pRB deficient cells.
CERC controls cyclin E expression in RB -/-cells but dissociates from CERM earlier than in wt cells
Luciferase reporter constructs driven by the cyclin E promoter (wt or mutated within CERM) were stably transfected into 3T3 cells established from MEFs deficient for pRB (M.Classon and E.Harlow, in preparation). Reporter expression was then analyzed during the cell cycle as described previously for the Swiss 3T3 transfectants. The wt cyclin E promoter-luciferase construct (proCE) yielded a 10-fold increase with kinetics that reflect the activation of the endogenous cyclin E gene in these cells, i.e. reaching a peak level of activation in G 1 several hours earlier than in wt cells (Herrera et al., 1996; Hurford et al., 1997) (Figure 11A ). Remarkably, as in pRB positive cells [ Figure 3 ; our unpublished results on control 3T3 fibroblasts isolated from wt MEFs (M.Classon and E.Harlow, in preparation)], these kinetics are accelerated for the CERM mutants, proCE-ΔCERM/E2FXmut and proCE-ΔCERM/ATmut ( Figure 11A) .
Consistent with the functional behavior of CERM in these RB -/-cells, this activation of the cyclin E promoter coincides with the dissociation of the CERC complex from CERM during the G 0 /G 1 -S progression in EMSAs ( Figure 11B ). In vivo footprints of CERM were performed as described in Figure 2 using genomic DNAs prepared from serum starved Rb -/-, p130 -/-, p130 -/-p107 -/-and wt MEFs treated with DMS. The DNA ladders shown correspond to the (-) strand of the ϩ7/ϩ49 nts region of the mouse cyclin E promoter. (B) Pocket proteins are interchangeable in CERC complexes in wt and mutant MEFs. EMSAs were performed as described in Figure 4 using cellular extracts prepared from wt or mutants MEFs as indicated. The presence of pocket proteins and of E2F4 in CERCs was detected as described in Figure 5 using the antibodies indicated. Figure 4 with the CERM probe and whole-cell extracts prepared from synchronized 3T3 fibroblasts established from Rb -/-MEFs. Cells were synchronizd as above and time points after serum stimulation are indicated above the lanes.
Altogether, these experiments demonstrate that CERM is functional in pRB deficient cells, where it acts as a dominant repressor element that controls the timing of expression of the cyclin E gene via its association with a CERC protein complex. Thus, the early induction of cyclin E in these cells compared with wt cells is clearly not due to a lack of CERM/CERC activity but rather to a premature dissociation of CERC from CERM in G 1 . This finding implies that the signaling pathway that controls CERC dissociation is altered in a pRB-deficient background. Although the identity of this pRB-dependent pathway is not revealed by the present work, this provides a novel explanation for the de-regulation of cyclin E expression in RB -/-cells.
Discussion
Mammalian cyclin E is both required and rate limiting for entry into S phase of the cell cycle. Its presence is periodic, reflecting the transient activation of the cyclin E promoter that peaks at the G 1 /S transition and then decays during S phase. Our study offers important new insights into the transcriptional mechanisms that control this cell cycle-dependent expression.
We concentrated on the role of the transcription factor E2F, which exerts positive and negative controls on G 1 cell cycle-regulated genes. It has been shown that combined mutation of two E2F sites located nearby the initiation site of transcription in the human promoter had a net positive effect on cyclin E promoter activity during G phase (Othani et al., 1995) . This observation suggested that E2F-mediated repression might control the cell cycledependent expression of the cyclin E promoter (Othani et al., 1995) . This model is strongly substantiated by our in vivo analysis of DNA-protein contacts in the mouse cyclin E promoter during the cell cycle. We show that only one of the E2F sites (a non-canonical E2F site referred as E2FX) located near the transcription start site is involved in repression. It functions as a dominant repressor element during G 1 , acting to prevent any cyclin E expression until cells reach the G 1 /S boundary. A number of criteria demonstrate that this is not simply another example of E2F-dependent repression through a typical E2F recognition sequence (for review see Sardet et al., 1997; Dyson, 1998; Nevins, 1998) . The two-component architecture, the kinetics of occupation and the protein complex bound, distinguish this E2FX from canonical E2F sites.
The promoter region centered around the E2FX site was the only one which was occupied in a cell cycledependent fashion. The protected bases extended beyond the E2FX site to an AT-rich sequence located five nucleotides upstream. Remarkably, both sequences were bound by proteins when the cyclin E gene was silent (i.e. in G 0 and G 1 ) and no longer contacted when it was expressed (i.e. in late G 1 -S). The possibility that this reflected cell cycle regulation through interaction with a repressor in G 0 and G 1 was confirmed by functional assays. That is, mutations in either the E2FX or the AT sequence led to a premature expression of the reporter gene in G 1 without changes in its level of activation. These data indicated that the AT-rich sequence and the contiguous E2FX site formed a unique regulatory element that we termed CERM, which acted solely as a transcriptional repressor. Notably, CERM has no role in the level of cyclin E activation at the G 1 /S transition. Instead, another region of the mouse cyclin E promoter appeared indispensable for efficient transcription (Figure 3 ; Botz et al., 1996) . This region, located immediately upstream of the major initiation site, harbors multiple SP1 sites and possibly a variant E2F site (termed E2FI) that are constitutively occupied by proteins in vivo (Figure 2) . Nevertheless, the repressive effect mediated by CERM is dominant over these upstream activating sequences, its main function being to delay cyclin E expression until cells reach the G 1 /S boundary.
The reason why cells delay cyclin E expression is currently unknown, as is the actual fonctional role of the cyclin E kinase. The current model is that cyclin E regulates entry into S phase, possibly acting as a master switch for an unidentified all-or-nothing event essential for the initiation of DNA replication (Hua et al., 1997; Krude et al., 1997; Duronio et al., 1998) .
A number of characteristics displayed by CERM are similar to the class of G 0 /G 1 repressor module termed CDE/E2F-CHR Zwicker et al., 1995; Bennett et al., 1996; Huet et al., 1996; . These include its location, pattern and kinetics of in vivo occupation, the cooperative function of its elements and its dominant repressive effect. However, a number of features differentiate CERM from CDE/E2F-CHR regulatory elements. First, the sequence and location of the AT-rich element in CERM clearly differs from that of the CHR. Moreover, the protein complex that interacts with CERM differs from those that have been proposed to bind on the CDE/E2F-CHR. In the B-myb promoter, the GC-rich motif (CDE/E2F) binds all known E2F complexes with high efficiency in vitro (Lam and Watson, 1993; Bennett et al., 1996; Liu et al., 1996; Zwicker et al., 1996) . However, the cell cycle pattern of in vitro binding (EMSA complexes) does not reflect the regulated occupation of the same CDE/E2F sequence in vivo, nor is it consistent with functional analyses (Bennett et al., 1996) . Thus, the role and nature of E2F complexes in the CDE/ E2F-CHR-mediated repression of the B-myb promoter are still uncertain. Similarly, the role of E2Fs in the repression of the cdc25C, cdc2 and cyclin A genes remains highly controversial. In vitro, CDE/CCRE sequences either do not bind E2Fs in vitro (cdc25C gene; Liu et al., 1997) , or do so very weakly via E2F ternary complexes (cdc2 and cyclin A gene) (Tommasi and Pfeifer, 1995; Zerfass et al., 1996; Liu et al., 1998) . While other reports disagree with this Huet et al., 1996; Philips et al., 1998) , these data support the notion that the whole CDE/ CCRE-CHR modules in the cdc2, cdc25C and cyclin A promoters bind efficiently an unidentified factor, named CDF1, which is clearly distinct from E2F and does not associate directly with pocket proteins (Liu et al., 1997 (Liu et al., , 1998 .
Our initial data also suggested that E2F might not be involved in CERM-mediated repression. Indeed, neither recombinant E2F complexes nor cellular E2F/DP heterodimers bound to a CERM probe in EMSAs while they bound strongly to a genuine E2F site ( Figure 7A ). Moreover, EMSA complexes formed between a CERM probe and cellular extracts were poorly competed by the E2 probe, and vice versa ( Figure 7B ). To our surprise, the cellular complex formed on CERM, termed CERC, unambiguously contained E2F4/DP1 and pocket proteins. Nevertheless, affinity purified CERC does not bind to typical E2F sites and it sediments as a large complex in glycerol gradients that is distinct from other E2F-containing complexes. Thus, CERC represents a novel E2F-containing multiprotein complex, the size and binding behaviors of which differ from previously described E2F complexes. Importantly, CERC fulfilled all the criteria expected of bona fide CERM-binding activity: CERC was abundant in quiescent cells and gradually disappeared upon progression through G 1 and S, with kinetics that correlates perfectly with the in vivo occupation of the CERM module and with the transcriptional induction of the cyclin E gene. Moreover, CERC reappeared as cells moved into their second G 1 , extending its role in cyclin E regulation to exponentially growing cells. Finally, in agreement with the functional analysis of CERM, CERC is only able to bind CERM when both the AT-rich and the E2FX sequences are intact.
We propose that the CERM repressor element represents a new type of two-component repressor element which shows weak affinity for E2Fs except when E2F and pocket proteins are associated with an unidentified partner(s) within the CERC complex. The requirement for the AT-rich sequence of CERM in vivo and in vitro suggests that CERC also contains an AT-element binding protein that co-operates with E2F-pocket protein complexes to bind CERM efficiently. Possibly, its role could be to foster E2F binding by inducing local conformational changes in chromatin to allow greater E2F access. Consistent with this model, in the absence of CERC, the AT-stretch might, by virtue of its structural rigidity, assume a specific structure in DNA that decreases access to the adjacent E2FX site. This mechanism could explain why, after CERC dissociates from CERM, free E2Fs that are abundant from mid G 1 to S phase are prevented from binding to the E2FX site. Such a structural effect of AT-rich sequences has been observed in Amt1-mediated transcription (Zhu and Thiele, 1996) .
CERC always contains a member of the pRB protein family. In synchronized Swiss 3T3 cells, CERC contains exclusively p130 in quiescent cells and predominantly p107 in growing cells. On the other hand, pRB and pRB complexes are barely detectable in these cells (even using nuclear extracts) and could not be found in CERC. However, in quiescent MEFs carrying inactivated p130 and p107 alleles, CERM binds a CERC-like activity which contains pRB (Figure 10) . Thus, p107, p130 and pRB are all potential components of CERC and thus are likely capable of functional compensation on CERM as they do in other functions (Dyson, 1998, Mulligan and . CERC also always contains E2F4 and DP1, in agreement with the established functional overlaps between p107, p130 and pRB in the regulation of this E2F in growing wt cells (Smith et al., 1996) as well as in pocket protein deficient cells (Sardet et al., 1995 (Sardet et al., , 1997 Moberg et al., 1996; Hurford et al., 1997; Nevins, 1998) .
The interchangeable nature of the pocket proteins in CERC is consistent with the normal cell cycle regulation of cyclin E expression in p130 -/-and p107 -/-p130 -/-double knockout cells (Hurford et al., 1997) . In direct contrast, the same cells do show de-repression of the CDE/E2F-CHR/DRS-regulated genes, cdc2, E2F1, cyclin A and B-myb (Hurford et al., 1997; . This further supports the idea that CERM and E2F/CDE-CHR/DRS modules are regulated by distinct types of complexes.
Given the altered timing of cyclin E expression in RB -/-MEFs ( Figure 11A ; Herrera et al., 1996; Hurford et al., 1997; , which resembles the effect of CERM mutation, we were surprised to find that CERC was intact in these cells arrested in G 0 (Figures 10 and  11) . Indeed, our analysis clearly shows that the CERM/ CERC repressor is still functional in these cells from G 0 and early G 1 . As in wt cells, its dissociation coincides with cyclin E induction ( Figure 11A ). However, this dissociation occurs earlier in pRB-deficient cells ( Figure 11B ) than in other cells, strongly suggesting that the premature induction of cyclin E in a pRB-deficient background is a consequence of the premature dissociation of CERC from CERM in mid G 1 . This finding implies that the signaling pathway that controls CERC dissociation is altered in a pRB-deficient background and provides a novel explanation for the de-regulation of cyclin E expression in RB -/-cells.
In conclusion, the identification and characterization of CERM/CERC explains how some E2F binding sites can be strictly involved in transcriptional repression. Moreover, its role as a timer of cyclin E expression establishes this regulatory complex as a master switch which gates cell cycle progression. As such, it is possible that a number of other cell cycle genes might also be controled by a CERC/CERM mechanism.
Materials and methods
Cell culture, cell synchronization and cell cycle analysis Swiss 3T3 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL) supplemented with 10% (v/v) fetal calf serum (FCS) (Biomedia), and primary mouse fibroblasts in DMEM with 10% heat-inactivated FCS (IFCS) (Biowhitaker). 3T3 fibroblasts established from MEFs were isolated as described previously (Todaro et al., 1965 ; M.Classon and E.Harlow, in preparation) and grown in DMEM with 10% inactivated newborn calf serum (Sigma). All these cell lines were grown at 37°C in a 5% CO 2 -containing atmosphere.
For cell cycle synchronization experiments, Swiss 3T3, MEFs and 3T3 isolated from MEFs were grown to 80% confluence and made quiescent in DMEM 0% FCS for 24 h, 0.2% IFCS for 36 h, or 0% for 72 h, respectively. Cells were stimulated to re-enter the cell cycle by 10% serum addition. DNA content was analysed by FACScan (Becton Dickinson) analysis of propidium iodide-labeled cells or by indirect immunofluorescence analysis of BrdU-labeled attached cells as previously described (Sardet et al., 1995; Huet et al., 1996) . For BrdUlabeling, synchronized cells were grown on coverslips and incubated with 100 μM bromodeoxyuridine for 1 h prior to fixation.
Isolation of the mouse cyclin E promoter and reporter plasmids, and mutagenesis
The mouse genomic library has been described previously (Cobrinik et al., 1996) and was screened with the 5Ј end of the mouse cyclin E cDNA. According to the published sequence (Botz et al., 1996) and proposed transcription start site, a 1 kb BamHI fragment overlaping the transcription start site was cloned in the BglII site of the promoterless reporter plasmid pGL2-basic (proCE), containing the firefly luciferase gene as a reporter (Promega) . cyclin E reporter constructs in pGL2-basic bearing the E2FX (proCE-ΔCERM/E2FXmut), AT (proCE-ΔCERM/ ATmut) or E2FI-sp1 (proCE-ΔE2FI-sp1) mutations were generated by PCR with the following primers: CE/E2FX25mut, TTTTTAAATGTA-GAGCTCGAAGCC; CE/TAmut, TTCTGCAATGTCCCGCTCGAA-GCCGGGCGCAGGAGCAGCC; CE/E2FI-sp1mut, GGCCGCTGAGG-GGCTCGCAGCCCTCGGTACGGTACGCGAGTACGGG-ACGGTACCG, and verified by sequencing.
Transfection, reporter assay
Swiss 3T3 cells or 3T3 fibroblasts (2ϫ10 5 ) isolated from MEFs per 6 cmdiameter dish were transfected with 0.2 μg of pCH110 (β-galactosidase expression vector), 0.2 μg of pCI-neo (neomycin resistance expression vector from Promega) and 2 μg of proCE, proCE-ΔCERM/E2FXmut, proCE-ΔCERM/mutAT or proCE-ΔE2FI-sp1 using 20 μl lipofect-AMINE (Gibco-BRL) in 2 ml of OptiMEM (Gibco-BRL) for 3 h at 37°C in a 5% CO 2 atmosphere as described by the supplier (Gibco-BRL). Neomycin-resistant populations of transfectant cells stably expressing these reporters were selected in DMEM with 10% serum and 500 μg/ml G-418 for 2 weeks. Selected cells were then serum-starved as described above and used for luciferase and β-galactosidase reporter assays at various time points following serum readdition. For luciferase assays, cell extracts prepared from 2ϫ10 5 cells per 6 cm-diameter dish were analyzed using standard protocols as described previously (Hateboer et al., 1998) . Luciferase activity values were normalized to the β-galactosidase activity to account for variations in transfection efficiencies. β-galactosidase assays were performed as described previously (Hateboer et al., 1998) .
Northern blot analyses
Total RNA was isolated from wt or transfected Swiss 3T3 cells by guanidinium thyocyanate-phenol/chloroform extraction. Ten micrograms of total RNA were resolved by electrophoresis on 1% agarose gel containing formaldehyde and transferred to Nylon membrane (Hybond-N; Amersham). The same membrane was successively hybridized with 32 P-labeled probes derived from human cyclin E, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or luciferase (firefly) full-length cDNAs.
In vivo DMS genomic footprinting
In vivo DMS genomic footprinting with the LMPCR procedure was performed essentially as described elsewhere (Hateboer et al., 1998; Le Cam et al., 1999) . Cells (2ϫ10 6 ) per 14 cm-diameter dish were treated with the guanosine methylating agent DMS at 0.2% for 5 min at room temperature in their cell culture medium (DMEM, FCS) buffered with HEPES (20 mM final concentration), pH 7.4. After DMS treatment, cells were washed three times with cold PBS, 2% β-mercaptoethanol and then collected in 1 ml of lysis buffer (50 mM Tris pH 8, 20 mM EDTA, 1% SDS, 2% β-mercaptoethanol). Genomic DNA was isolated by three gentle extractions with phenol (pH 8) followed by two precipitations in 4 M ammonium acetate with three volumes of ethanol. DNA was then re-dissolved in 1 ml of water. As a reference, genomic DNA (1 mg/ml in water) from the same cell type was methylated in vitro with 0.5% DMS for 4 min at room temperature. Piperidine cleavage at methylated bases was performed in piperidine 1 N at 95°C for 30 min. Chemically cleaved samples were precipitated in ethanol, evaporated twice and finally resuspended to 0.4 mg/ml in water. Two micrograms of cleaved genomic DNA was used for LMPCR that were carried out as described previously (Hateboer et al., 1998; Le Cam et al., 1999) . The following primers were designed to analyze the upper and lower strands of the transcription start site region of the mouse cyclin E promoter: SCE4, AGCTCCTCGCTGGTCCGC; SCE5, CGGCGGCC-GCTGAGGGGC; and SCE6, CGGCGGCCGCTGAGGGGCTCGC-AG-3Ј; ASCE4, GGATCCGCGCCTGCCCCC; ASCE5, CCCCTA-CACCGCGCTGGCTG; ASCE6, CCCTACACCGCGCTGGCTGTCG-AGC. All reactions were performed in presence of 10% DMSO. Temperatures for PCRs were as follows: (i) first elongation, 15 min at 76°C. (ii) PCR amplification, 4 min at 95°C followed by 30 cycles of 1 min at 95°C, 2 min at 60°C, 3 min at 76°C, ending with 7 min at 76°C; (iii) Labeling, 4 min at 95°C followed by nine cycles of 1 min at 95°C, 2 min at 60°C, 3 min at 76°C in the presence of 32 P-labeled SCE 6 or ASCE6 primer {primers were 5Ј-end labeled with T4 polynucleotidekinase (New England Biolabs) and [γ-32 P]ATP (NEN)}. Specific activity of the labeled primer was 3ϫ10 6 c.p.m./pmol. Samples were loaded onto a 5% sequencing gel and run at 50 W. Dried gels were analyzed with a PhosphorImager from Molecular Dynamics, Inc.
EMSAs
Swiss 3T3 or MEF high-salt whole-cell extracts for EMSAs were prepared as follows: cells were detached with phosphate-buffered saline (PBS) and EDTA 5 mM, packed in Eppendorf tubes at 5000 g for 30 s, resuspended in two packed cell volumes of extraction buffer [20 mM HEPES pH 7.9, 0.58 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 30 mM NaF, 20 mM Na-β-glycerophosphate, 0.5 mM PMSF, 0.5 mM dithiothreitol (DTT), 16% glycerol], frozen (-70°C), then thawed (in ice) three times, and finally centrifuged at 100 000 g for 20 min (2°C). Protein concentration of supernatants was adjusted to 5 mg/ml with extraction buffer and samples were frozen at -70°C.
Recombinant E2F1, E2F4, DP1 and p130 were produced using a TNT-coupled reticulocyte lysate system (Promega) as described previously (Sardet et al., 1995; Vairo et al., 1995) . Double-stranded probes for EMSA: E2, GCATAAGTTTCGCGCCCTTTCTCAG (E2F consensus site from the adenovirus E2 promoter); E2mut, GCATAAGTTT-CGATCCCTTTCTCAG; CERM, CCGCGCGCTGGGATTTTTAAATG-TCCCGCTCGAAGCCG (nts ϩ7/ϩ45 of mouse cyclin E gene); CERM/ mutE2FX, CCGCGCGCTGGGATTTTTAAATGTAGAGCTCGAAGC-CG; CERM/mutAT, CCGCGCGCTGGGATTCTGCAATGTCCCGCT-CGAAGCCG. Probes were labeled by filling in 5Ј overhangs with [α-32 P]dCTP with Klenow (Gibco-BRL) or end-labeled with T4 polynucleotide kinase (New England Biolabs) and [γ-32 P]ATP. All probes were purified on polyacrylamide gels. EMSAs were performed as followed: 1 μl of in vitro-translated proteins or 5 μg of cell extract proteins were pre-incubated for 30 min at 22°C in 10 μl of EMSA buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 50 mM NaCl, 1 mM DTT, 10 mM β-glycerophosphate, 2.5 mM PNPP, 5% glycerol) and 0.5 μg of calf thymus genomic DNA (Pharmacia). Ten femtomoles of probe at 5ϫ10 6 c.p.m./pmol were then added for 30 min at 22°C before samples were run on 4.5% acrylamide non-denaturating gels in 0.25ϫ TBE at 22°C and 10 V/cm. For antibody perturbation experiments, antibodies were added to cell extracts during the pre-incubation period. Specificity of each antibody for its target was tested in preliminary experiments (data not shown), using recombinant proteins and the E2 probe. Antibodies were added as followed: anti-p130, 0.5 μl of monoclonal RB2, (Transduction laboratories); anti-p107, 1 μl of polyclonal C18, (Santa Cruz); anti-pRB, 1 μl of monoclonal 21C9 (Hurford et al., 1997) co-added with 0.5 μl of polyclonal M15 (Santa Cruz); anti-E2F1, 1 μl of polyclonal C20, (Santa Cruz); anti-E2F4, 0.1 μl of a mouse polyclonal antiserum (Vairo et al., 1995) ; anti-E2F3, 1 μl of polyclonal N20, (Santa Cruz); anti-E2F5, 1 μl of mouse monoclonal 274 (C.Sardet, unpublished reagent). Anti-DP1, 1 μl of mouse monoclonal (E.Lam, unpublished reagent).
Native glycerol gradients
Whole-cell extracts (2.5 mg) from G 0 -arrested Swiss 3T3 cells were applied to a 10-50% glycerol gradient (8 ml) in EMSA buffer without glycerol and DTT (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 50 mM NaCl). Gradients were centrifuged at 40 000 r.p.m. in an SW60 rotor for 12 h at 4°C. Samples were collected in 20 fractions of 200 μl starting at the top of the gradient. Three microliters of each fraction was used for EMSAs with the E2 and CERM probes. Twenty microliters of each fraction were also used to performed a Western blot as follows: proteins were separated by SDS-PAGE and transferred to Immobilon P membranes (Millipore). Membranes were incubated with a monoclonal
